_id
691722553c536f8df2316979
Ticker
TRVI
Name
Trevi Therapeutics Inc
Exchange
NASDAQ
Address
195 Church Street, New Haven, CT, United States, 06510
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.trevitherapeutics.com
Description
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF; phase 2 clinical trial in patients with pruritus; and phase 2b/3 clinical trial in patients with prurigo nodularis. Trevi Therapeutics, Inc. has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Last Close
13.17
Volume
2469590
Current Price
12.77
Change
-3.037205770690967
Last Updated
2025-12-04T14:28:20.715Z
Image
https://logo.clearbit.com/www.trevitherapeutics.com
Ipo Date
2019-05-07T00:00:00.000Z
Market Cap
1756752896
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9910249999999999
Sentiment Sources
8
Rating
4.875
Target Price
21
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
13916000
Operating Income
-13916000
Interest Expense
0
Pretax Income
-11817000
Net Income
-11802000
Eps
-0.0813342141117053
Dividends Per Share
-
Shares Outstanding
128230134
Income Tax Expense
-15000
EBITDA
-11779000
Operating Margin
-
Total Other Income Expense Net
2099000
Cash
56869000
Short Term Investments
138058000
Receivables
-
Inventories
-
Total Current Assets
198299000
Property Plant Equipment
954000
Total Assets
199356000
Payables
2709000
Short Term Debt
296000
Long Term Debt
-
Total Liabilities
9568000
Equity
189788000
Depreciation
38000
Change In Working Capital
-169000
Cash From Operations
-10880000
Capital Expenditures
12000
Cash From Investing
-50938000
Cash From Financing
1629000
Net Change In Cash
-60189000
PE
-
PB
9.763476464370772
ROE
-6.218517503741016
ROA
-5.920062601577078
FCF
-10892000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
13916000
Quarters > 0 > income Statement > operating Income
-13916000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-11817000
Quarters > 0 > income Statement > net Income
-11802000
Quarters > 0 > income Statement > eps
-0.0813342141117053
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
145104986
Quarters > 0 > income Statement > income Tax Expense
-15000
Quarters > 0 > income Statement > EBITDA
-11779000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2099000
Quarters > 0 > balance Sheet > cash
56869000
Quarters > 0 > balance Sheet > short Term Investments
138058000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
198299000
Quarters > 0 > balance Sheet > property Plant Equipment
954000
Quarters > 0 > balance Sheet > total Assets
199356000
Quarters > 0 > balance Sheet > payables
2709000
Quarters > 0 > balance Sheet > short Term Debt
296000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9568000
Quarters > 0 > balance Sheet > equity
189788000
Quarters > 0 > cash Flow > net Income
-11802000
Quarters > 0 > cash Flow > depreciation
38000
Quarters > 0 > cash Flow > change In Working Capital
-169000
Quarters > 0 > cash Flow > cash From Operations
-10880000
Quarters > 0 > cash Flow > capital Expenditures
12000
Quarters > 0 > cash Flow > cash From Investing
-50938000
Quarters > 0 > cash Flow > cash From Financing
1629000
Quarters > 0 > cash Flow > net Change In Cash
-60189000
Quarters > 0 > ratios > PE
-0.0813342141117053
Quarters > 0 > ratios > PB
9.763476464370772
Quarters > 0 > ratios > ROE
-6.218517503741016
Quarters > 0 > ratios > ROA
-5.920062601577078
Quarters > 0 > ratios > FCF
-10892000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
38000
Quarters > 1 > income Statement > gross Profit
-38000
Quarters > 1 > income Statement > operating Expenses
13722000
Quarters > 1 > income Statement > operating Income
-13722000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-12322000
Quarters > 1 > income Statement > net Income
-12301000
Quarters > 1 > income Statement > eps
-0.09436872345093311
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
130350391
Quarters > 1 > income Statement > income Tax Expense
-21000
Quarters > 1 > income Statement > EBITDA
-12284000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1400000
Quarters > 1 > balance Sheet > cash
117058000
Quarters > 1 > balance Sheet > short Term Investments
86827000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
207228000
Quarters > 1 > balance Sheet > property Plant Equipment
1043000
Quarters > 1 > balance Sheet > total Assets
208339000
Quarters > 1 > balance Sheet > payables
2974000
Quarters > 1 > balance Sheet > short Term Debt
286000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9846000
Quarters > 1 > balance Sheet > equity
198493000
Quarters > 1 > cash Flow > net Income
-12301000
Quarters > 1 > cash Flow > depreciation
38000
Quarters > 1 > cash Flow > change In Working Capital
1051000
Quarters > 1 > cash Flow > cash From Operations
-10101000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-2610000
Quarters > 1 > cash Flow > cash From Financing
110395000
Quarters > 1 > cash Flow > net Change In Cash
97684000
Quarters > 1 > ratios > PE
-0.09436872345093311
Quarters > 1 > ratios > PB
8.386061438287497
Quarters > 1 > ratios > ROE
-6.197195870887135
Quarters > 1 > ratios > ROA
-5.904319402512251
Quarters > 1 > ratios > FCF
-10101000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
37000
Quarters > 2 > income Statement > gross Profit
-37000
Quarters > 2 > income Statement > operating Expenses
11470000
Quarters > 2 > income Statement > operating Income
-11470000
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-10351000
Quarters > 2 > income Statement > net Income
-10340000
Quarters > 2 > income Statement > eps
-0.08791713342530338
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
117610750
Quarters > 2 > income Statement > income Tax Expense
-11000
Quarters > 2 > income Statement > EBITDA
-10314000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1119000
Quarters > 2 > balance Sheet > cash
19374000
Quarters > 2 > balance Sheet > short Term Investments
83883000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
105621000
Quarters > 2 > balance Sheet > property Plant Equipment
1142000
Quarters > 2 > balance Sheet > total Assets
107004000
Quarters > 2 > balance Sheet > payables
1421000
Quarters > 2 > balance Sheet > short Term Debt
276000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7547000
Quarters > 2 > balance Sheet > equity
99457000
Quarters > 2 > cash Flow > net Income
-10340000
Quarters > 2 > cash Flow > depreciation
37000
Quarters > 2 > cash Flow > change In Working Capital
-4099000
Quarters > 2 > cash Flow > cash From Operations
-13477000
Quarters > 2 > cash Flow > capital Expenditures
13477000
Quarters > 2 > cash Flow > cash From Investing
-9951000
Quarters > 2 > cash Flow > cash From Financing
8705000
Quarters > 2 > cash Flow > net Change In Cash
-14723000
Quarters > 2 > ratios > PE
-0.08791713342530338
Quarters > 2 > ratios > PB
15.100890611017826
Quarters > 2 > ratios > ROE
-10.396452738369346
Quarters > 2 > ratios > ROA
-9.663190161115471
Quarters > 2 > ratios > FCF
-26954000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
146000
Quarters > 3 > income Statement > cost Of Revenue
38000
Quarters > 3 > income Statement > gross Profit
-38000
Quarters > 3 > income Statement > operating Expenses
12205000
Quarters > 3 > income Statement > operating Income
-12243000
Quarters > 3 > income Statement > interest Expense
1000
Quarters > 3 > income Statement > pretax Income
-11399000
Quarters > 3 > income Statement > net Income
-11415000
Quarters > 3 > income Statement > eps
-0.10767883983733335
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
106009686
Quarters > 3 > income Statement > income Tax Expense
16000
Quarters > 3 > income Statement > EBITDA
-11360000
Quarters > 3 > income Statement > operating Margin
-8385.616438356165
Quarters > 3 > income Statement > total Other Income Expense Net
844000
Quarters > 3 > balance Sheet > cash
34097000
Quarters > 3 > balance Sheet > short Term Investments
73525000
Quarters > 3 > balance Sheet > receivables
532000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
109428000
Quarters > 3 > balance Sheet > property Plant Equipment
1229000
Quarters > 3 > balance Sheet > total Assets
110900000
Quarters > 3 > balance Sheet > payables
3414000
Quarters > 3 > balance Sheet > short Term Debt
285000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
11256000
Quarters > 3 > balance Sheet > equity
99644000
Quarters > 3 > cash Flow > net Income
-11415000
Quarters > 3 > cash Flow > depreciation
38000
Quarters > 3 > cash Flow > change In Working Capital
1009000
Quarters > 3 > cash Flow > cash From Operations
-9550000
Quarters > 3 > cash Flow > capital Expenditures
7000
Quarters > 3 > cash Flow > cash From Investing
-23872000
Quarters > 3 > cash Flow > cash From Financing
51467000
Quarters > 3 > cash Flow > net Change In Cash
18045000
Quarters > 3 > ratios > PE
-0.10767883983733335
Quarters > 3 > ratios > PB
13.585802358596604
Quarters > 3 > ratios > ROE
-11.455782586006181
Quarters > 3 > ratios > ROA
-10.293056807935077
Quarters > 3 > ratios > FCF
-9557000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-65.45890410958904
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
147000
Annuals > 0 > income Statement > gross Profit
-147000
Annuals > 0 > income Statement > operating Expenses
51524000
Annuals > 0 > income Statement > operating Income
-51524000
Annuals > 0 > income Statement > interest Expense
4000
Annuals > 0 > income Statement > pretax Income
-47941000
Annuals > 0 > income Statement > net Income
-47911000
Annuals > 0 > income Statement > eps
-0.47417116121103936
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
101041573
Annuals > 0 > income Statement > income Tax Expense
-30000
Annuals > 0 > income Statement > EBITDA
-47790000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3583000
Annuals > 0 > balance Sheet > cash
34097000
Annuals > 0 > balance Sheet > short Term Investments
73525000
Annuals > 0 > balance Sheet > receivables
532000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
109428000
Annuals > 0 > balance Sheet > property Plant Equipment
1229000
Annuals > 0 > balance Sheet > total Assets
110900000
Annuals > 0 > balance Sheet > payables
3414000
Annuals > 0 > balance Sheet > short Term Debt
285000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11256000
Annuals > 0 > balance Sheet > equity
99644000
Annuals > 0 > cash Flow > net Income
-47911000
Annuals > 0 > cash Flow > depreciation
147000
Annuals > 0 > cash Flow > change In Working Capital
6827000
Annuals > 0 > cash Flow > cash From Operations
-38256000
Annuals > 0 > cash Flow > capital Expenditures
35000
Annuals > 0 > cash Flow > cash From Investing
-21528000
Annuals > 0 > cash Flow > cash From Financing
61484000
Annuals > 0 > cash Flow > net Change In Cash
1700000
Annuals > 0 > ratios > PE
-0.47417116121103936
Annuals > 0 > ratios > PB
13.892151560555577
Annuals > 0 > ratios > ROE
-48.082172534221826
Annuals > 0 > ratios > ROA
-43.20198376916141
Annuals > 0 > ratios > FCF
-38291000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
123000
Annuals > 1 > income Statement > gross Profit
-123000
Annuals > 1 > income Statement > operating Expenses
33923000
Annuals > 1 > income Statement > operating Income
-33923000
Annuals > 1 > income Statement > interest Expense
391000
Annuals > 1 > income Statement > pretax Income
-29097000
Annuals > 1 > income Statement > net Income
-29065000
Annuals > 1 > income Statement > eps
-0.2934869238473782
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
99033373
Annuals > 1 > income Statement > income Tax Expense
-32000
Annuals > 1 > income Statement > EBITDA
-28583000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
4826000
Annuals > 1 > balance Sheet > cash
32397000
Annuals > 1 > balance Sheet > short Term Investments
50574000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
87547000
Annuals > 1 > balance Sheet > property Plant Equipment
1559000
Annuals > 1 > balance Sheet > total Assets
89403000
Annuals > 1 > balance Sheet > payables
1809000
Annuals > 1 > balance Sheet > short Term Debt
306000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6856000
Annuals > 1 > balance Sheet > equity
82547000
Annuals > 1 > cash Flow > net Income
-29065000
Annuals > 1 > cash Flow > depreciation
123000
Annuals > 1 > cash Flow > change In Working Capital
-3847000
Annuals > 1 > cash Flow > cash From Operations
-31710000
Annuals > 1 > cash Flow > capital Expenditures
137000
Annuals > 1 > cash Flow > cash From Investing
59428000
Annuals > 1 > cash Flow > cash From Financing
-7910000
Annuals > 1 > cash Flow > net Change In Cash
19808000
Annuals > 1 > ratios > PE
-0.2934869238473782
Annuals > 1 > ratios > PB
16.43617829963536
Annuals > 1 > ratios > ROE
-35.21024386107309
Annuals > 1 > ratios > ROA
-32.51009473955013
Annuals > 1 > ratios > FCF
-31847000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
43000
Annuals > 2 > income Statement > gross Profit
-43000
Annuals > 2 > income Statement > operating Expenses
29907000
Annuals > 2 > income Statement > operating Income
-29907000
Annuals > 2 > income Statement > interest Expense
780000
Annuals > 2 > income Statement > pretax Income
-29188000
Annuals > 2 > income Statement > net Income
-29152000
Annuals > 2 > income Statement > eps
-0.45167550121036854
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
64541911
Annuals > 2 > income Statement > income Tax Expense
-36000
Annuals > 2 > income Statement > EBITDA
-29864000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
719000
Annuals > 2 > balance Sheet > cash
12589000
Annuals > 2 > balance Sheet > short Term Investments
107921000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
122616000
Annuals > 2 > balance Sheet > property Plant Equipment
194000
Annuals > 2 > balance Sheet > total Assets
123015000
Annuals > 2 > balance Sheet > payables
2857000
Annuals > 2 > balance Sheet > short Term Debt
7025000
Annuals > 2 > balance Sheet > long Term Debt
2151000
Annuals > 2 > balance Sheet > total Liabilities
15556000
Annuals > 2 > balance Sheet > equity
107459000
Annuals > 2 > cash Flow > net Income
-29152000
Annuals > 2 > cash Flow > depreciation
43000
Annuals > 2 > cash Flow > change In Working Capital
-1231000
Annuals > 2 > cash Flow > cash From Operations
-28175000
Annuals > 2 > cash Flow > capital Expenditures
159000
Annuals > 2 > cash Flow > cash From Investing
-107373000
Annuals > 2 > cash Flow > cash From Financing
111307000
Annuals > 2 > cash Flow > net Change In Cash
-24241000
Annuals > 2 > ratios > PE
-0.45167550121036854
Annuals > 2 > ratios > PB
8.228479519630742
Annuals > 2 > ratios > ROE
-27.128486213346488
Annuals > 2 > ratios > ROA
-23.69792301751819
Annuals > 2 > ratios > FCF
-28334000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
50000
Annuals > 3 > income Statement > gross Profit
-50000
Annuals > 3 > income Statement > operating Expenses
32476000
Annuals > 3 > income Statement > operating Income
-32476000
Annuals > 3 > income Statement > interest Expense
1202000
Annuals > 3 > income Statement > pretax Income
-33961000
Annuals > 3 > income Statement > net Income
-33940000
Annuals > 3 > income Statement > eps
-1.4858931432685998
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
22841481
Annuals > 3 > income Statement > income Tax Expense
-21000
Annuals > 3 > income Statement > EBITDA
-32709000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1485000
Annuals > 3 > balance Sheet > cash
36830000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
241000
Annuals > 3 > balance Sheet > inventories
-241000
Annuals > 3 > balance Sheet > total Current Assets
37957000
Annuals > 3 > balance Sheet > property Plant Equipment
184000
Annuals > 3 > balance Sheet > total Assets
38475000
Annuals > 3 > balance Sheet > payables
2849000
Annuals > 3 > balance Sheet > short Term Debt
5953000
Annuals > 3 > balance Sheet > long Term Debt
8652000
Annuals > 3 > balance Sheet > total Liabilities
21400000
Annuals > 3 > balance Sheet > equity
17075000
Annuals > 3 > cash Flow > net Income
-33940000
Annuals > 3 > cash Flow > depreciation
50000
Annuals > 3 > cash Flow > change In Working Capital
1509000
Annuals > 3 > cash Flow > cash From Operations
-28946000
Annuals > 3 > cash Flow > capital Expenditures
159000
Annuals > 3 > cash Flow > cash From Investing
-107373000
Annuals > 3 > cash Flow > cash From Financing
20775000
Annuals > 3 > cash Flow > net Change In Cash
-8171000
Annuals > 3 > ratios > PE
-1.4858931432685998
Annuals > 3 > ratios > PB
18.326693393850658
Annuals > 3 > ratios > ROE
-198.7701317715959
Annuals > 3 > ratios > ROA
-88.21312540610786
Annuals > 3 > ratios > FCF
-29105000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
16
Valuation > metrics > PE
-0.0813342141117053
Valuation > metrics > PB
9.763476464370772
Valuation > final Score
20
Valuation > verdict
225.4% Overvalued
Profitability > metrics > ROE
-6.218517503741016
Profitability > metrics > ROA
-5.951618515474108
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05041414631062027
Risk > metrics > Interest Coverage
-366.2105263157895
Risk > final Score
-1405
Risk > verdict
High
Liquidity > metrics > Current Ratio
65.98968386023294
Liquidity > metrics > Quick Ratio
65.98968386023294
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1384
Prev Risks > 1
-1180
Prev Risks > 2
-48912
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:31:24.585Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.08
Earnings History > 0 > eps Estimate
-0.1
Earnings History > 0 > eps Difference
0.02
Earnings History > 0 > surprise Percent
20
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.09
Earnings History > 1 > eps Estimate
-0.1
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
10
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.09
Earnings History > 2 > eps Estimate
-0.09
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-18
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.11
Earnings History > 3 > eps Estimate
-0.1171
Earnings History > 3 > eps Difference
0.0071
Earnings History > 3 > surprise Percent
6.0632
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.13
Earnings History > 4 > eps Estimate
-0.12
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-8.3333
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.12
Earnings History > 5 > eps Estimate
-0.11
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-9.0909
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-0.09
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-22.2222
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.08
Earnings History > 7 > eps Estimate
-0.09
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
11.1111
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.08
Earnings History > 8 > eps Estimate
-0.09
Earnings History > 8 > eps Difference
0.01
Earnings History > 8 > surprise Percent
11.1111
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.07
Earnings History > 9 > eps Estimate
-0.08
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
12.5
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.06
Earnings History > 10 > eps Estimate
-0.07
Earnings History > 10 > eps Difference
0.01
Earnings History > 10 > surprise Percent
14.2857
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-16
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.06
Earnings History > 11 > eps Estimate
-0.1
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
40
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.12
Earnings History > 12 > eps Estimate
-0.13
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
7.6923
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.14
Earnings History > 13 > eps Estimate
-0.18
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
22.2222
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.24
Earnings History > 14 > eps Estimate
-0.29
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
17.2414
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.28
Earnings History > 15 > eps Estimate
-0.3
Earnings History > 15 > eps Difference
0.02
Earnings History > 15 > surprise Percent
6.6667
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.34
Earnings History > 16 > eps Estimate
-0.4
Earnings History > 16 > eps Difference
0.06
Earnings History > 16 > surprise Percent
15
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.47
Earnings History > 17 > eps Estimate
-0.46
Earnings History > 17 > eps Difference
-0.01
Earnings History > 17 > surprise Percent
-2.1739
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.43
Earnings History > 18 > eps Estimate
-0.52
Earnings History > 18 > eps Difference
0.09
Earnings History > 18 > surprise Percent
17.3077
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.51
Earnings History > 19 > eps Estimate
-0.44
Earnings History > 19 > eps Difference
-0.07
Earnings History > 19 > surprise Percent
-15.9091
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-11
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.41
Earnings History > 20 > eps Estimate
-0.51
Earnings History > 20 > eps Difference
0.1
Earnings History > 20 > surprise Percent
19.6078
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-13
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.41
Earnings History > 21 > eps Estimate
-0.48
Earnings History > 21 > eps Difference
0.07
Earnings History > 21 > surprise Percent
14.5833
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.48
Earnings History > 22 > eps Estimate
-0.44
Earnings History > 22 > eps Difference
-0.04
Earnings History > 22 > surprise Percent
-9.0909
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-16
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.37
Earnings History > 23 > eps Estimate
-0.51
Earnings History > 23 > eps Difference
0.14
Earnings History > 23 > surprise Percent
27.451
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-14
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.41
Earnings History > 24 > eps Estimate
-0.47
Earnings History > 24 > eps Difference
0.06
Earnings History > 24 > surprise Percent
12.766
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-12
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.63
Earnings History > 25 > eps Estimate
-0.41
Earnings History > 25 > eps Difference
-0.22
Earnings History > 25 > surprise Percent
-53.6585
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-13
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-13.85
Earnings History > 26 > eps Estimate
-0.52
Earnings History > 26 > eps Difference
-13.33
Earnings History > 26 > surprise Percent
-2563.4615
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-02-27
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-21
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.59
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.59
Earnings History > 28 > surprise Percent
-
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF; phase 2 clinical trial in patients with pruritus; and phase 2b/3 clinical trial in patients with prurigo nodularis. Trevi Therapeutics, Inc. has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATrevi Therapeutics stock hits all-time high of 14.01 USD By Investing.com - Investing.com Nigeria
12/11/2025
Trevi Therapeutics stock hits all-time high of 14.01 USD By Investing.com Investing.com Nigeria
Read more →Marshall Wace LLP Has $13.55 Million Stock Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat
12/11/2025
Marshall Wace LLP Has $13.55 Million Stock Position in Trevi Therapeutics, Inc. $TRVI MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$21
Analyst Picks
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 80.14% of the total shares of Trevi Therapeutics Inc
1.
NEA Management Company, LLC(10.8578%)
since
2025/06/30
2.
Rubric Capital Management LP(7.0061%)
since
2025/06/30
3.
BlackRock Inc(6.7377%)
since
2025/06/30
4.
Vanguard Group Inc(4.3659%)
since
2025/06/30
5.
Vivo Capital, LLC(3.6853%)
since
2025/06/30
6.
AllianceBernstein L.P.(3.5157%)
since
2025/06/30
7.
Woodline Partners LP(3.3228%)
since
2025/06/30
8.
Siren, L.L.C.(3.2344%)
since
2025/06/30
9.
Octagon Capital Advisors LP(3.0154%)
since
2025/06/30
10.
MPM Oncology Impact Management LP(2.7977%)
since
2025/06/30
11.
Orbimed Advisors, LLC(2.7168%)
since
2025/06/30
12.
Vanguard Total Stock Mkt Idx Inv(2.5644%)
since
2025/07/31
13.
Affinity Asset Advisors, LLC(2.0809%)
since
2025/06/30
14.
Marshall Wace Asset Management Ltd(2.0348%)
since
2025/06/30
15.
Balyasny Asset Management LLC(1.9334%)
since
2025/06/30
16.
Fidelity Select Biotechnology(1.7726%)
since
2025/07/31
17.
AB Small Cap Growth A(1.7158%)
since
2025/07/31
18.
iShares Russell 2000 ETF(1.5059%)
since
2025/08/31
19.
State Street Corp(1.5051%)
since
2025/06/30
20.
Geode Capital Management, LLC(1.4673%)
since
2025/06/30
21.
Point72 Asset Management, L.P.(1.4195%)
since
2025/06/30
22.
Viking Global Investors LP(1.2671%)
since
2025/06/30
23.
Eventide Asset Management, LLC(1.1343%)
since
2025/06/30
24.
Eventide Healthcare & Life Sciences I(1.1343%)
since
2025/06/30
25.
Citadel Advisors Llc(1.0833%)
since
2025/06/30
26.
BlackRock Advantage Small Cap Core Instl(0.6938%)
since
2025/07/31
27.
Vanguard Institutional Extnd Mkt Idx Tr(0.652%)
since
2025/07/31
28.
Fidelity Small Cap Index(0.6253%)
since
2025/06/30
29.
iShares Russell 2000 Growth ETF(0.5427%)
since
2025/08/31
30.
Wellington Global Hlthcr Eq USD G Ac(0.5096%)
since
2025/07/31
31.
Principal SmallCap Growth I Instl(0.4222%)
since
2025/07/31
32.
AB US Small Cap Growth Collective Tr W(0.4161%)
since
2025/07/31
33.
Biotech Growth Ord(0.404%)
since
2025/05/31
34.
MEDICAL BioHealth EUR Acc(0.3405%)
since
2025/06/30
35.
iShares Biotechnology ETF(0.3404%)
since
2025/08/31
36.
Fidelity Extended Market Index(0.3274%)
since
2025/07/31
37.
Vanguard Russell 2000 ETF(0.2963%)
since
2025/07/31
38.
AB Small Cap Core Z(0.2352%)
since
2025/07/31
39.
SPDR® S&P Pharmaceuticals ETF(0.2331%)
since
2025/08/31
40.
Invesco Dorsey Wright Healthcare MomtETF(0.2245%)
since
2025/08/29
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.08
EPS Estimate
-0.1
EPS Difference
0.02
Surprise Percent
20%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.